Venlafaksin (Turkish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Venlafaksin" in Turkish language version.

refsWebsite

Global rank Turkish rank

13doi.org

2^nd place

4^th place

13nih.gov

4^th place

11^th place

10web.archive.org

1^st place

5archive.org

6^th place

2drugs.com

399^th place

156^th place

2clincalc.com

3,912^th place

2,106^th place

2worldcat.org

5^th place

8^th place

1mayoclinic.org

1,610^th place

1,902^nd place

1books.google.com

3^rd place

5^th place

1mayoclinic.com

3,634^th place

4,257^th place

1stanford.edu

179^th place

236^th place

1tga.gov.au

3,984^th place

3,256^th place

1titck.gov.tr

low place

4,315^th place

archive.org

"Treatment of pain syndromes with venlafaxine". Pharmacotherapy. 24 (5): 621-9. May 2004. doi:10.1592/phco.24.6.621.34748. PMID 15162896.
"Venlafaxine hydrochloride for the treatment of hot flashes". The Annals of Pharmacotherapy. 37 (11): 1703-7. 2003. doi:10.1345/aph.1C483. PMID 14565812.
"The role of venlafaxine in the treatment of obsessive-compulsive disorder". Annals of Pharmacotherapy. 39 (1): 136-40. January 2005. doi:10.1345/aph.1E362. PMID 15585743.
Courtney DB (2004). "Selective serotonin reuptake inhibitor and venlafaxine use in children and adolescents with major depressive disorder: a systematic review of published randomized controlled trials". Canadian Journal of Psychiatry. 49 (8): 557-63. doi:10.1177/070674370404900807. PMID 15453105.
The Maudsley Prescribing Guidelines in Psychiatry. illustrated. John Wiley & Sons. 2012. ISBN 978-0-470-97948-8.

books.google.com

The Opioid System as the Interface between the Brain's Cognitive and Motivational Systems. Academic Press. 2018. s. 73. ISBN 978-0-444-64168-7. 27 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Ağustos 2021.

clincalc.com

"The Top 300 of 2021". ClinCalc. 18 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Şubat 2021.
"Venlafaxine - Drug Usage Statistics". ClinCalc. 12 Nisan 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Şubat 2021.

doi.org

"Treatment of pain syndromes with venlafaxine". Pharmacotherapy. 24 (5): 621-9. May 2004. doi:10.1592/phco.24.6.621.34748. PMID 15162896.
"Venlafaxine hydrochloride for the treatment of hot flashes". The Annals of Pharmacotherapy. 37 (11): 1703-7. 2003. doi:10.1345/aph.1C483. PMID 14565812.
"Efficacy and adverse effects of venlafaxine in children and adolescents with ADHD: a systematic review of non-controlled and controlled trials". Reviews on Recent Clinical Trials. 8 (1): 2-8. March 2013. doi:10.2174/1574887111308010002. PMID 23157376.
"Extended-release formulation of venlafaxine in the treatment of post-traumatic stress disorder". Expert Review of Neurotherapeutics. 7 (6): 603-15. June 2007. doi:10.1586/14737175.7.6.603. PMID 17563244.
"The role of venlafaxine in the treatment of obsessive-compulsive disorder". Annals of Pharmacotherapy. 39 (1): 136-40. January 2005. doi:10.1345/aph.1E362. PMID 15585743.
"Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis". Lancet. 373 (9665): 746-58. February 2009. doi:10.1016/S0140-6736(09)60046-5. PMID 19185342.
"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis". Lancet. 391 (10128): 1357-1366. April 2018. doi:10.1016/S0140-6736(17)32802-7. PMC 5889788 $2. PMID 29477251.
"A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability". Journal of Clinical Psychopharmacology. 26 (5): 482-8. 2006. doi:10.1097/01.jcp.0000239790.83707.ab. PMID 16974189.
"Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor". International Clinical Psychopharmacology. 23 (3): 113-9. 2008. doi:10.1097/YIC.0b013e3282f424c2. PMID 18408525.
Courtney DB (2004). "Selective serotonin reuptake inhibitor and venlafaxine use in children and adolescents with major depressive disorder: a systematic review of published randomized controlled trials". Canadian Journal of Psychiatry. 49 (8): 557-63. doi:10.1177/070674370404900807. PMID 15453105.
Thase (2017). "A meta-analysis of the efficacy of venlafaxine extended release 75–225 mg/day for the treatment of major depressive disorder". Current Medical Research and Opinion. Informa UK Limited. 33 (2): 317-326. doi:10.1080/03007995.2016.1255185. ISSN 0300-7995. PMID 27794623.
Furukawa (2020). "Optimal Dose of Selective Serotonin Reuptake Inhibitors, Venlafaxine, and Mirtazapine in Major Depression: A Systematic Review and Dose-Response Meta-Analysis". Focus (American Psychiatric Publishing). American Psychiatric Association Publishing. 18 (2): 211-219. doi:10.1176/appi.focus.18204. ISSN 1541-4094. PMC 7587875 $2. PMID 33343239.
"Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine". Arch. Gen. Psychiatry. 69 (6): 580-7. June 2012. doi:10.1001/archgenpsychiatry.2011.2048. PMC 3367101 $2. PMID 22309973.

drugs.com

"Venlafaxine Hydrochloride Monograph for Professionals". Drugs.com. AHFS. 26 Kasım 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 Aralık 2018.
"venlafaxine-hydrochloride". The American Society of Health-System Pharmacists. 26 Kasım 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Nisan 2011.

mayoclinic.com

"Beyond hormone therapy: Other medicines may help". Hot flashes: Ease the discomfort of menopause. Mayo Clinic. 2005. 25 Şubat 2005 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Ağustos 2005.

mayoclinic.org

"Antidepressants: Another weapon against chronic pain". Mayo Clinic. 25 Ocak 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Ocak 2020.

nih.gov

ncbi.nlm.nih.gov

"Treatment of pain syndromes with venlafaxine". Pharmacotherapy. 24 (5): 621-9. May 2004. doi:10.1592/phco.24.6.621.34748. PMID 15162896.
"Venlafaxine hydrochloride for the treatment of hot flashes". The Annals of Pharmacotherapy. 37 (11): 1703-7. 2003. doi:10.1345/aph.1C483. PMID 14565812.
"Efficacy and adverse effects of venlafaxine in children and adolescents with ADHD: a systematic review of non-controlled and controlled trials". Reviews on Recent Clinical Trials. 8 (1): 2-8. March 2013. doi:10.2174/1574887111308010002. PMID 23157376.
"Extended-release formulation of venlafaxine in the treatment of post-traumatic stress disorder". Expert Review of Neurotherapeutics. 7 (6): 603-15. June 2007. doi:10.1586/14737175.7.6.603. PMID 17563244.
"The role of venlafaxine in the treatment of obsessive-compulsive disorder". Annals of Pharmacotherapy. 39 (1): 136-40. January 2005. doi:10.1345/aph.1E362. PMID 15585743.
"Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis". Lancet. 373 (9665): 746-58. February 2009. doi:10.1016/S0140-6736(09)60046-5. PMID 19185342.
"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis". Lancet. 391 (10128): 1357-1366. April 2018. doi:10.1016/S0140-6736(17)32802-7. PMC 5889788 $2. PMID 29477251.
"A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability". Journal of Clinical Psychopharmacology. 26 (5): 482-8. 2006. doi:10.1097/01.jcp.0000239790.83707.ab. PMID 16974189.
"Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor". International Clinical Psychopharmacology. 23 (3): 113-9. 2008. doi:10.1097/YIC.0b013e3282f424c2. PMID 18408525.
Courtney DB (2004). "Selective serotonin reuptake inhibitor and venlafaxine use in children and adolescents with major depressive disorder: a systematic review of published randomized controlled trials". Canadian Journal of Psychiatry. 49 (8): 557-63. doi:10.1177/070674370404900807. PMID 15453105.
Thase (2017). "A meta-analysis of the efficacy of venlafaxine extended release 75–225 mg/day for the treatment of major depressive disorder". Current Medical Research and Opinion. Informa UK Limited. 33 (2): 317-326. doi:10.1080/03007995.2016.1255185. ISSN 0300-7995. PMID 27794623.
Furukawa (2020). "Optimal Dose of Selective Serotonin Reuptake Inhibitors, Venlafaxine, and Mirtazapine in Major Depression: A Systematic Review and Dose-Response Meta-Analysis". Focus (American Psychiatric Publishing). American Psychiatric Association Publishing. 18 (2): 211-219. doi:10.1176/appi.focus.18204. ISSN 1541-4094. PMC 7587875 $2. PMID 33343239.
"Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine". Arch. Gen. Psychiatry. 69 (6): 580-7. June 2012. doi:10.1001/archgenpsychiatry.2011.2048. PMC 3367101 $2. PMID 22309973.

stanford.edu

med.stanford.edu

"Medications". Stanford University School of Medicine, Center for Narcolepsy. 7 Şubat 2003. 21 Ağustos 2007 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Eylül 2007.

tga.gov.au

ebs.tga.gov.au

"Efexor-XR (venlafaxine hydrochloride)" (PDF). TGA eBS. 12 Mayıs 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Mayıs 2021.

titck.gov.tr

"Arşivlenmiş kopya" (PDF). 3 Ağustos 2021 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 3 Ağustos 2021.

web.archive.org

"Venlafaxine Hydrochloride Monograph for Professionals". Drugs.com. AHFS. 26 Kasım 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 Aralık 2018.
"Antidepressants: Another weapon against chronic pain". Mayo Clinic. 25 Ocak 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Ocak 2020.
"The Top 300 of 2021". ClinCalc. 18 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Şubat 2021.
"Venlafaxine - Drug Usage Statistics". ClinCalc. 12 Nisan 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Şubat 2021.
"venlafaxine-hydrochloride". The American Society of Health-System Pharmacists. 26 Kasım 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Nisan 2011.
The Opioid System as the Interface between the Brain's Cognitive and Motivational Systems. Academic Press. 2018. s. 73. ISBN 978-0-444-64168-7. 27 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Ağustos 2021.
"Beyond hormone therapy: Other medicines may help". Hot flashes: Ease the discomfort of menopause. Mayo Clinic. 2005. 25 Şubat 2005 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Ağustos 2005.
"Medications". Stanford University School of Medicine, Center for Narcolepsy. 7 Şubat 2003. 21 Ağustos 2007 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Eylül 2007.
"Efexor-XR (venlafaxine hydrochloride)" (PDF). TGA eBS. 12 Mayıs 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Mayıs 2021.
"Arşivlenmiş kopya" (PDF). 3 Ağustos 2021 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 3 Ağustos 2021.

worldcat.org

Thase (2017). "A meta-analysis of the efficacy of venlafaxine extended release 75–225 mg/day for the treatment of major depressive disorder". Current Medical Research and Opinion. Informa UK Limited. 33 (2): 317-326. doi:10.1080/03007995.2016.1255185. ISSN 0300-7995. PMID 27794623.
Furukawa (2020). "Optimal Dose of Selective Serotonin Reuptake Inhibitors, Venlafaxine, and Mirtazapine in Major Depression: A Systematic Review and Dose-Response Meta-Analysis". Focus (American Psychiatric Publishing). American Psychiatric Association Publishing. 18 (2): 211-219. doi:10.1176/appi.focus.18204. ISSN 1541-4094. PMC 7587875 $2. PMID 33343239.